// App-Quantinova.ai

4572 : Real world experience and biomarkers of nivolumab in dutch advanced renal-cell carcinoma patients.

Researchers

Presenter

  • Saskia Lisa Verhaart

Principal Investigators

  • Sjoukje Oosting

  • Astrid Van Der Veldt

  • Susanne Osanto

  • Maureen J.B. Aarts

  • Danny Houtsma

  • Frank P.J. Peters

  • Gerard Groenewegen

  • Axel Bex

  • Sasja F. Mulder

  • Loes M. Pronk

  • Metin Tascilar

  • Paul Hamberg

  • Maartje Los

  • Gerard Vreugdenhil

  • Marco Polee

  • Albert J. Ten Tije

  • John B. A. G. Haanen

  • Alfonsus Johannes Maria van den Eertwegh

Medical Centers

  • VU University Medical Center, Amsterdam, Netherlands

  • Radboud University Medical Center, Njmegen, Netherlands

  • Department of Medical Oncology, University Medical Center Groningen, Groningen, Netherlands

  • Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands

  • Leiden University Medical Centre, Leiden, Netherlands

  • Maastricht University Medical Center, Maastricht, Netherlands

  • Haga Hospitals, Den Haag, Netherlands

  • Zuyderland Hospital, Sittard, Netherlands

  • University Medical Center Utrecht, Utrecht, Netherlands

  • Netherlands Cancer Institute (NKI), Amsterdam, Netherlands

  • Netherlands Cancer Institute (NKI), Amsterdam, Netherlands

  • Isala Clinics, Zwolle, Netherlands

  • Franciscus Gasthuis & Vllietland, Rotterdam, Netherlands

  • St Antonius Hospital, Nieuwegein, Netherlands

  • Maxima Medical Center, Eindhoven, Netherlands

  • Medical Center Leeuwarden, Leeuwarden, Netherlands

  • Amphia hospital, Breda, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Lactate dehydrogenase

  • X-Ray Repair Cross Complementing 1

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved